Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-18

Clinical Trial Update: A Study of DC6001 Tablet in Healthy Chinese Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 study update of DC6001 Tablet in healthy Chinese adults; recruitment ongoing with Stargardt Disease listed as the condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DC6001 Tablet (DC6001)

Snippet

Sponsor: Heronova Pharmaceuticals | Conditions: Stargardt Disease | Phase 1 | Status: RECRUITING